title: Intracerebroventricular injection of dibutyryl cyclic adenosine 3',5'-monophosphate increases hypothalamic levels of neuropeptide Y.
abstract: This investigation examined in vivo the relationship between the nucleotide cAMP and hypothalamic levels of two peptides, neuropeptide Y (NPY) and galanin (GAL), which are known to potentiate feeding behavior. In brain-cannulated rats, third ventricular injections of N6,2'-O-dibutyryl cyclic adenosine 3',5'-monophosphate ((Bu)2cAMP, 25 micrograms), compared to saline, caused a significant increase in NPY levels in the arcuate nucleus (ARC) and medial parvocellular portion of the paraventricular nucleus (mPVN), while having no impact in other hypothalamic areas. These site-specific changes in NPY occurred in the absence of any alteration in circulating levels of insulin, corticosterone, aldosterone or glucose, or of changes in hypothalamic levels of GAL. These findings implicate cAMP as having regulatory functions within specific hypothalamic NPY-synthesizing neurons, projecting from the ARC to the mPVN, that are believed to be involved in energy homeostasis.
authors.affiliation: Rockefeller University, New York, NY 10021.
authors.forename: A
authors.initials: A
authors.lastname: Akabayashi
authors.forename: C T
authors.initials: CT
authors.lastname: Zaia
authors.forename: S M
authors.initials: SM
authors.lastname: Gabriel
authors.forename: I
authors.initials: I
authors.lastname: Silva
authors.forename: W K
authors.initials: WK
authors.lastname: Cheung
authors.forename: S F
authors.initials: SF
authors.lastname: Leibowitz
mesh_terms: D000450:Aldosterone / Q000097:blood; D000704:Analysis of Variance; D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000187:drug effects / Q000378:metabolism; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D003994:Bucladesine / Q000008:administration & dosage / Q000494:pharmacology*; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D003345:Corticosterone / Q000097:blood; D019004:Galanin; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007276:Injections, Intraventricular; D007328:Insulin / Q000097:blood; D008297:Male; D009478:Neuropeptide Y / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism; D009928:Organ Specificity; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects / Q000378:metabolism; D010455:Peptides / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values
chemical_list: D001786:Blood Glucose; D007328:Insulin; D009478:Neuropeptide Y; D009479:Neuropeptides; D010455:Peptides; D000450:Aldosterone; D003994:Bucladesine; D019004:Galanin; D003345:Corticosterone